March 12, 2015 article Open access Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer Science DOI: 10.1126/science.aaa1348 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 46 stored of 8,075 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access The contribution of rare germline variants to the immune landscape of breast cancer 2026 Genome Medicine article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 0 citations NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy 2026 Nature Communications article Medicine CAR-T cell therapy research Open access 1 citations Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better? 2025 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 8 citations Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial 2025 Nature Medicine article Medicine Nonmelanoma Skin Cancer Studies Open access 15 citations Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol 2025 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access 2 citations Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors 2025 Nature Reviews Nephrology review Medicine Cancer Immunotherapy and Biomarkers 40 citations Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening 2024 Nature Biotechnology article Medicine CAR-T cell therapy research Open access cited by 1 patent 52 citations Melanoma neoantigen vaccines: Are we getting more personal now? 2024 Med article Immunology and Microbiology Immunotherapy and Immune Responses Open access 5 citations Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer 2024 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access 34 citations Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in Non-Small Cell Lung Cancer 2023 medRxiv preprint Medicine Cancer Immunotherapy and Biomarkers Open access 1 citations A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo 2023 Nature Cancer article Medicine Acute Myeloid Leukemia Research Open access cited by 2 patents 39 citations Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma 2023 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers 23 citations Meta-analysis of preclinical measures of efficacy in immune checkpoint blockade therapies and comparison to clinical efficacy estimates 2023 Translational Medicine Communications review Medicine Cancer Immunotherapy and Biomarkers Open access 2 citations Lack of detectable neoantigen depletion in treatment-naïve cancers 2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access 0 citations Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer 2023 Tumor Biology article Medicine Cancer Immunotherapy and Biomarkers Open access 4 citations Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications 2023 Cancers article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access 28 citations Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma 2023 Nature Reviews Clinical Oncology review Medicine Cutaneous Melanoma Detection and Management 50 citations Neoantigen-directed therapeutics in the clinic: where are we? 2023 Trends in cancer review Immunology and Microbiology Immunotherapy and Immune Responses Open access 34 citations MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression 2023 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 5 patents 34 citations Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy 2023 Cellular and Molecular Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access 72 citations 1–20 of 46 Page 1 / 3 Next → References 0